On January 31, 2017, the French National Drug and Health Product Agency ("ANSM") issued an updated FAQ related to the authorization and declaration procedures of manufacturing, import, and ...

Following extensive discussions, GenSight reached alignment with ANSM on a plan to open the LUMEVOQ ® AAC program. The agency has agreed that the authorization of a focused dose-ranging study could ...

France will introduce in 2026 a “fast-track” pathway aimed at accelerating the authorisation of certain mono-national clinical trials. Reserved in particular for early-phase studies, serious diseases ...

LONDON – France's Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) has published draft guidelines on the cybersecurity of medical devices, becoming the first national ...

France’s ANSM Issues Warning About NSAIDs Following Safety Review France’s National Agency for the Safety of Medicines and Health Products (ANSM) has published a warning about the use of nonsteroidal ...

The company’s state-of-the-art sterile drug product manufacturing site in Saint-Beauzire, France, opened in February 2023. Pharmaceutical process development and API manufacturing company CARBOGEN ...

GRENOBLE, France and MINNEAPOLIS, July 17, 2025 /PRNewswire/ -- UroMems, a global company developing innovative, mechatronics technology to treat stress urinary incontinence (SUI), received ...

The French National Agency for the Safety of Medicines and Health Products (ANSM) has authorised FineHeart to commence a nonrandomised first-in-human trial in the country to assess the FlowMaker ...

PARIS – The French National Agency for the Safety of Medicinal and Healthcare Products (ANSM), has published its latest annual report on the drugs and medical devices market in France. This body, ...

Amid rising concern over long-term use and side effects, France has launched a national campaign to raise awareness about the risks associated with commonly prescribed anti-anxiety and sleep ...